// App-Quantinova.ai

502 : Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor patients (SCAN): The diagnostic process of GEP-NETs in Australia, Canada, China, France, Germany, the United Kingdom, and the United States of America.

Researchers

Presenter

  • Mark McDonnell

Principal Investigators

  • Catherine Bouvier

  • Marianne E. Pavel

  • Harjit Singh

  • James R. Howe

  • Simron Singh

  • Jie Chen

  • Dirk Van Genechten

  • Elyse Gellerman

  • Sugandha Dureja

  • Simone Leyden

  • Christine Rodien-Louw

  • Teodora Kolarova

  • Dermot O'Toole

Medical Centers

  • NET Patient Network, Dublin, Ireland

  • Neuroendocrine Cancer UK, Leamington Spa, United Kingdom

  • Charite-Universitatsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany

  • Prince Court Medical Centre 39, Jalan Kia Peng, Kuala Lumpur, Malaysia

  • University of Iowa, Carver College of Medicine, Iowa City, IA

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

  • VZW NET & Men Kanker Belgium, Kortrijk, Belgium

  • NET Research Foundation (NETRF), Boston, MA

  • Action Cancer Hospital, New Delhi, Delhi, India

  • NeuroEndocrine Cancer Australia, Victoria, Australia

  • APTED Association de Patients Porteurs de Tumeurs Endocrines Diverses, Lyon, France

  • International Neuroendocrine Cancer Alliance, Boston, MA

  • Saint James's Hospital, Dublin, Ireland

Locations

  • Ireland

  • United Kingdom

  • Germany

  • Malaysia

  • United States

  • Canada

  • China

  • Belgium

  • India

  • Australia

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroendocrine tumors

  • Gastroenteropancreatic neuroendocrine carcinomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A